1 / 10

Non Tuberculous Mycobacteria Infection Market

NTMI is ubiquitous, aerobic, non-motile, acid-fast bacteria commonly found in soil and water (present in environment).<br>

DelveInsight
Download Presentation

Non Tuberculous Mycobacteria Infection Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non Tuberculous Mycobacteria Infection (NTMI) NTMI affects the lungs, but may also affect any other body site, however person-to- person transmission of the disease is very uncommon. NTMI classified into four distinct clinical syndromes: chronic pulmonary disease, lymphadenitis, cutaneous disease, and disseminated disease. NTM lung disease often affects elderly people with chronic lung disease and may be a manifestation of a complex genetic disorder determined by interactions among multiple genes, as well as environmental exposures. NTMI is ubiquitous, aerobic, non-motile, acid-fast bacteria commonly found in soil and water (present in environment). 01 02 03 04 • DelveInsight © 2019 | All rights reserved

  2. NTMI Epidemiology CASES • More than 80,000NTMI cases were observed in Japan in 2017. Prevalence Approximately 366,800 NTMI prevalent cases were observed in the United States in 2017. INFECTED • More than 180,000 cases of NTM (Infected) were observed in the United States in 2017. PREVALENCE Approximately 10,200 NTMI infected prevalent cases were observed in France in 2017. • DelveInsight © 2019 | All rights reserved

  3. NTMI Market NTMI therapeutic market is dependent on the use of antibiotics either as a monotherapy of in combination based on the severity level of the infections. There are a large number of clinical trials evaluating potential treatments. Hence, increasing R&D activities, and positive results of these trials shall fuel NTMI therapeutic market size. NTMI is relatively resistant to antibiotics and can become more resistant if only one antibiotic is used to treat NTMI. 01 02 03 04 05 Azithromycin, Ciprofloxacin, minocycline are the commonly prescribed oral antibiotics for this infection, Cefoxitin and Imipenem are for intravenous antibiotics whereas Cefoxitin and Imipenem are the mostly used inhaled antibiotics. Ongoing trials on the use Nitric acid may bring a significant change in NTMI treatment algorithm. NTMI market size is expected to increase at a significant growth during the study period [2017-2028] • DelveInsight © 2019 | All rights reserved

  4. NTMI Emerging Drugs and Companies NTMI market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, and expected the launch of NTMI emerging therapies during the forecasted period of 2019-2028. Drug: RHB-204 By RedhillBiopharma Drug: Arikayce-MABSC by Insmed Corporation Drug: Molgramostim By Savara Pharma Drug: Thiolanox By Novoteris • DelveInsight © 2019 | All rights reserved

  5. Complete Information For complete information on NonTuberculous Mycobacteria Infection Market Insights, Epidemiology & Market Forecast-2028 please click the link below CLICK HERE OR Write Us At  info@delveinsight.com • DelveInsight © 2019 | All rights reserved

  6. About DelveInsight 2 1 3 Mission About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved

  7. Services by DelveInsight PharmDelve Forecasting OpportunityAssessment Consulting ReportStore MarketIntelligence Competitive Analysis Pipeline • DelveInsight © 2019 | All rights reserved

  8. Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved

  9. Pompe Disease 9

More Related